What is the best medication regimen, including dose and frequency, for a patient with major depressive disorder, generalized anxiety disorder, post‑traumatic stress disorder, and chronic pain?

Best Medication for MDD, Anxiety, PTSD, and Chronic Pain

Start with duloxetine 30 mg once daily for one week, then increase to 60 mg once daily. This single agent addresses all four conditions simultaneously and represents the most evidence-based first-line choice for this complex presentation 1.

Rationale for Duloxetine as First-Line

Duloxetine is uniquely positioned as the optimal medication because it:

• Treats chronic pain: FDA-approved and guideline-recommended as first-line for neuropathic pain with demonstrated efficacy 1
• Treats MDD: Proven efficacy for major depression 1
• Treats anxiety: Shows efficacy in generalized anxiety disorder 1
• Simple dosing: 60 mg once daily is as effective as divided dosing 1
• Favorable safety profile: No clinically significant ECG changes or blood pressure alterations, and aminotransferase monitoring is unnecessary 1

The most common adverse effect is nausea, which is substantially reduced by starting at 30 mg daily for one week before advancing to the therapeutic dose of 60 mg daily 1.

If Duloxetine Provides Partial Relief

Add pregabalin starting at 50 mg three times daily, increasing to 100 mg three times daily after 3-7 days as tolerated 1. Maximum dose is 600 mg daily in divided doses if needed 2.

Pregabalin augmentation is supported by guidelines for:

• Additional pain control (particularly neuropathic components) 1
• Anxiety symptoms 1
• More efficient GI absorption than gabapentin 2

Important: Reduce dose in renal insufficiency and titrate more slowly in elderly or medically frail patients 2.

Addressing PTSD Specifically

For PTSD symptoms, the evidence supports SSRIs (particularly sertraline or paroxetine) as first-line 3, 4, 5. However, duloxetine's SNRI mechanism provides overlapping benefit, and adding a separate SSRI would create unnecessary polypharmacy and drug interaction risks.

If PTSD symptoms remain inadequately controlled on duloxetine:

• Consider mirtazapine augmentation 15-30 mg at bedtime 3, 5
  • Evidence shows benefit for PTSD (RR 0.45,95% CI 0.22-0.94) 3
  • Particularly useful if insomnia is prominent 6
  • Also addresses anxiety and depression 6
  • Sedating properties can be advantageous for trauma-related sleep disturbance

If First-Line Approach Fails

After adequate trials (4-8 weeks at therapeutic doses) 1:

1. Switch to venlafaxine 37.5 mg once or twice daily, titrate by 75 mg weekly to 150-225 mg daily 1

   • Alternative SNRI with similar multi-condition coverage
   • Caution: Monitor blood pressure; taper when discontinuing to avoid withdrawal syndrome 1

2. Consider tricyclic antidepressants (nortriptyline or desipramine preferred over amitriptyline for tolerability) 2

   • Start 10-25 mg nightly, increase every 3-5 days to 50-150 mg nightly 2
   • Critical safety measure: Obtain screening ECG if patient >40 years old; limit to <100 mg/day with cardiac disease 1
   • Requires 6-8 weeks for adequate trial 1

Common Pitfalls to Avoid

• Don't start with benzodiazepines: Despite anxiety/PTSD, benzodiazepines were ineffective for PTSD and may worsen outcomes 5
• Don't use opioids as first-line for chronic pain: No evidence of long-term benefit, significant harm potential, and increased risk of addiction 7
• Don't combine multiple antidepressants initially: Start with duloxetine monotherapy before adding agents
• Don't undertitrate: Many patients receive subtherapeutic doses; ensure adequate dosing before declaring treatment failure
• Don't forget renal dosing: Both pregabalin and gabapentin require dose adjustment in renal insufficiency 1

Timeline Expectations

• Nausea from duloxetine: Peaks in first week, improves with continued use 1
• Pain relief: May begin within 2-4 weeks 1
• Mood/anxiety improvement: Typically 4-6 weeks for full effect
• PTSD symptoms: May require 6-8 weeks for meaningful improvement 3

Monitoring

Reassess pain intensity, mood, anxiety, and PTSD symptoms every 2-4 weeks during titration. Target pain reduction to ≤3/10 and substantial functional improvement 1. If pain remains ≥4/10 after adequate duloxetine trial, add pregabalin rather than switching 1.